Keith Hovda

Title: Keith Hovda: Innovator in Taxane Conjugate Analysis

Introduction

Keith Hovda is an accomplished inventor based in Kent, WA (US). He has made significant contributions to the field of pharmaceutical analysis, particularly in the determination of taxane conjugates. His innovative approach has led to the development of a patented method that enhances the understanding of drug formulations.

Latest Patents

Hovda holds a patent titled "Method for determining the amount of conjugated taxane in polyglutamic acid-taxane conjugates." This invention relates to a method for determining the amount of conjugated taxane, specifically paclitaxel, in a PGA-taxane conjugate. The method involves reacting the PGA-taxane conjugate with a specific compound to yield unbound taxane and a PGA hydrazide, followed by determining the amount of unbound taxane. This patent showcases Hovda's expertise in pharmaceutical chemistry and his commitment to advancing drug analysis techniques. He has 1 patent to his name.

Career Highlights

Throughout his career, Keith Hovda has worked with notable companies in the pharmaceutical industry. He has been associated with Cell Therapeutics, Inc. and Cell Therapeutics Europe S.r.l., where he contributed to innovative projects aimed at improving cancer treatment methodologies. His work has had a lasting impact on the field, particularly in the area of drug formulation and analysis.

Collaborations

Hovda has collaborated with esteemed colleagues such as Stefano Fazioni and Valeria Livi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical sector.

Conclusion

Keith Hovda is a notable inventor whose work in taxane conjugate analysis has paved the way for advancements in pharmaceutical research. His patented method demonstrates his dedication to improving drug analysis techniques, making significant contributions to the field.